Selective downregulation of retinoic acid-inducible gene i within the intestinal epithelial compartment in crohn's disease

Inflammatory Bowel Diseases

Volumn 17, Issue 9, 2011, Pages 1943-1954

  Funke, Benjamin ^a   Lasitschka, Felix ^a   Roth, Wilfried ^a,b   Penzel, Roland ^a   Meuer, Stefan ^a   Saile, Maria ^c   Gretz, Norbert ^c   Sido, Bernd ^a   Schirmacher, Peter ^a   Autschbach, Frank ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Crohn's disease; inflammatory bowel disease; pattern recognition receptor; retinoic acid inducible gene I; RIG I

Indexed keywords

BUDESONIDE; CYCLOSPORIN A; MESALAZINE; PATTERN RECOGNITION RECEPTOR; PREDNISONE; RETINOIC ACID; RETINOIC ACID INDUCIBLE GENE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CROHN DISEASE; COLON TUMOR; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GLOBAL EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM MUCOSA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INTESTINAL EPITHELIAL COMPARTMENT; INTESTINE EPITHELIUM CELL; LASER MICRODISSECTION; MALE; PANCREAS CANCER; PRIORITY JOURNAL; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS; VILLOUS ADENOMA;

ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79956302548     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21572     Document Type: Article

References (39)

1. Sands BE,. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007; 42: 16-25. (Pubitemid 46351421)
2. Cobrin GM, Abreu MT,. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev. 2005; 206: 277-295. (Pubitemid 41105176)
3. Braat H, Peppelenbosch MP, Hommes DW,. Immunology of Crohn's disease. Ann N Y Acad Sci. 2006; 1072: 135-154. (Pubitemid 44448449)
4. Yamamoto-Furusho JK, Korzenik JR,. Crohn's disease: innate immunodeficiency? World J Gastroenterol. 2006; 12: 6751-6755. (Pubitemid 44811394)
5. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003; 124: 140-146. (Pubitemid 36055347)
6. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603. (Pubitemid 32531408)
7. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002; 70: 845-857. (Pubitemid 34259301)
8. Tanaka M, Saito H, Kusumi T, et al. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J Gastroenterol Hepatol. 2001; 16: 1353-1359. (Pubitemid 34107402)
9. Wehkamp J, Chu H, Shen B, et al. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett. 2006; 580: 5344-5350. (Pubitemid 44419568)
10. Yamamoto-Furusho JK, Podolsky DK,. Innate immunity in inflammatory bowel disease. World J Gastroenterol. 2007; 13: 5577-5580. (Pubitemid 350031477)
11. Burgemeister R, Gangnus R, Haar B, et al. High quality RNA retrieved from samples obtained by using LMPC (laser microdissection and pressure catapulting) technology. Pathol Res Pract. 2003; 199: 431-436. (Pubitemid 36974831)
12. Niyaz Y, Stich M, Sagmuller B, et al. Noncontact laser microdissection and pressure catapulting: sample preparation for genomic, transcriptomic, and proteomic analysis. Methods Mol Med. 2005; 114: 1-24.
13. Houseley J, Tollervey D,. The many pathways of RNA degradation. Cell. 2009; 136: 763-776.
14. Clement-Ziza M, Munnich A, Lyonnet S, et al. Stabilization of RNA during laser capture microdissection by performing experiments under argon atmosphere or using ethanol as a solvent in staining solutions. RNA. 2008; 14: 2698-2704.
15. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004; 53: 1658-1664. (Pubitemid 39434112)
16. Nenci A, Becker C, Wullaert A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007; 446: 557-561. (Pubitemid 46514732)
17. Pasparakis M,. IKK/NF-kappaB signaling in intestinal epithelial cells controls immune homeostasis in the gut. Mucosal Immunol. 2008; 1 (suppl 1): S54-57.
18. Funke B, Autschbach F, Kim S, et al. Functional characterisation of decoy receptor 3 in Crohn's disease. Gut. 2009; 58: 483-491.
19. Yoneyama M, Fujita T,. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev. 2009; 227: 54-65.
20. Abraham C, Cho JH,. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006; 12: 641-650. (Pubitemid 43977746)
21. Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004; 99: 2393-2404. (Pubitemid 40039371)
22. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002; 123: 86-91. (Pubitemid 34747528)
23. Chomczynski P, Sacchi N,. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156-159. (Pubitemid 17064313)
24. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001; 29: 365-371. (Pubitemid 34326681)
25. Brazma A, Parkinson H, Sarkans U, et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2003; 31: 68-71. (Pubitemid 36150335)
26. Parkinson H, Kapushesky M, Shojatalab M, et al. ArrayExpress-a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 2007; 35: D747-750. (Pubitemid 46056303)
27. Parkinson H, Sarkans U, Shojatalab M, et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 2005; 33: D553-555. (Pubitemid 40207935)
28. Rocca-Serra P, Brazma A, Parkinson H, et al. ArrayExpress: a public database of gene expression data at EBI. Comp Rend Biol. 2003; 326: 1075-1078. (Pubitemid 38016463)
29. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984; 32: 219-229. (Pubitemid 14184314)
30. Wu Z, Irizarry RA, Gentleman R, et al. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc. 2004; 99: 909-917. (Pubitemid 39665934)
31. Smyth GK,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3: Article3.
32. Wettenhall JM, Simpson KM, Satterley K, et al. affylmGUI: a graphical user interface for linear modeling of single channel microarray data. Bioinformatics. 2006; 22: 897-899.
33. Hochberg Y, Benjamini Y,. More powerful procedures for multiple significance testing. Stat Med. 1990; 9: 811-818. (Pubitemid 20343989)
34. Autschbach F, Giese T, Gassler N, et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch. 2002; 441: 500-513. (Pubitemid 35430467)
35. Z'Graggen K, Walz A, Mazzucchelli L, et al. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology. 1997; 113: 808-816. (Pubitemid 27381140)
36. Imada A, Ina K, Shimada M, et al. Coordinate upregulation of interleukin-8 and growth-related gene product-alpha is present in the colonic mucosa of inflammatory bowel. Scand J Gastroenterol. 2001; 36: 854-864. (Pubitemid 32656561)
37. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004; 5: 730-737. (Pubitemid 39023305)
38. Wang Y, Zhang HX, Sun YP, et al. Rig-I-/- mice develop colitis associated with downregulation of G alpha i2. Cell Res. 2007; 17: 858-868. (Pubitemid 47585114)
39. Su ZZ, Sarkar D, Emdad L, et al. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J Cell Physiol. 2007; 213: 502-510. (Pubitemid 47509733)